Abstract:Peto's paradox and the epidemiologic observation of the average six degrees of tumor prevalence are studied and hypothetically solved. A simple consideration, Petho's paradox challenges our intuitive understanding of cancer risk and prevalence. Our simple consideration is that the more a cell divides, the higher the chance of acquiring cancerous mutations, and so the larger or longer-lived organisms have more cells and undergo more cell divisions over their lifetime, expecting to have a higher risk of developing cancer. Paradoxically, it is not supported by the observations. The allometric scaling of species could answer the Peto paradox. Another paradoxical human epidemiology observation in six average mutations is necessary for cancer prevalence, despite the random expectations of the tumor causes. To solve this challenge, game theory could be applied. The inherited and random DNA mutations in the replication process nonlinearly drive cancer development. The statistical variance concept does not reasonably describe tumor development. Instead, the Darwinian natural selection principle is applied. The mutations in the healthy organism's cellular population can serve the species' evolutionary adaptation by the selective pressure of the circumstances. Still, some cells collect multiple uncorrected mutations, adapt to the extreme stress in the stromal environment, and develop subclinical phases of cancer in the individual. This process needs extensive subsequent DNA replications to heritage and collect additional mutations, which are only marginal alone. Still, together, they are preparing for the first stage of the precancerous condition. In the second stage, when one of the caretaker genes is accidentally mutated, the caused genetic instability prepares the cell to fight for its survival and avoid apoptosis. This can be described as a competitive game. In the third stage, the precancerous cell develops uncontrolled proliferation with the damaged gatekeeper gene and forces the new game strategy with binary cooperation with stromal cells for alimentation. In the fourth stage, the starving conditions cause a game change again, starting a cooperative game, where the malignant cells cooperate and force the cooperation of the stromal host, too. In the fifth stage, the resetting of homeostasis finishes the subclinical stage, and in the fifth stage, the clinical phase starts. The prevention of the development of mutated cells is more complex than averting exposure to mutagens from the environment throughout the organism's lifetime. Mutagenic exposure can increase the otherwise random imperfect DNA reproduction, increasing the likelihood of cancer development, but mutations exist. Toxic exposure is more challenging; it may select the tolerant cells on this particular toxic stress, so these mutations have more facility to avoid apoptosis in otherwise collected random mutational states.

Peto's paradox and the hallmarks of cancer: constructing an evolutionary framework for understanding the incidence of cancer

The multiple facets of Peto's paradox: a life-history model for the evolution of cancer suppression

Paradox resolved: The allometric scaling of cancer risk across species

Peto's paradox: Nature has used multiple strategies to keep cancer at bay while evolving long lifespans and large body masses. A systematic review

Evolutionary mechanism unifies the hallmarks of cancer

Peto's "Paradox" and Six Degrees of Cancer Prevalence

A modelling framework for cancer ecology and evolution

Characterizing the Ecological and Evolutionary Dynamics of Cancer

An Evolutionary Genetic Perspective on Cancer Biology

Cancer evolution: Darwin and beyond

[Evolution of cancer resistance in the animal kingdom]

Changing mutational and adaptive landscapes and the genesis of cancer

Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution

Critically assessing atavism, an evolution‐centered and deterministic hypothesis on cancer

Identifying key questions in the ecology and evolution of cancer

The temporal evolution of cancer hallmarks

From Churchill to Elephants: The Role of Protective Genes against Cancer

The molecular evolution of cancer associated genes in mammals

The evolutionary theory of cancer: challenges and potential solutions

Analysis of Cancer-Resisting Evolutionary Adaptations in Wild Animals and Applications for Human Oncology

Evolutionary perspective of cancer: myth, metaphors, and reality